Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Government of India...

    Government of India bans Fixed dose combination of Glucosamine, Ibuprofen

    Written by Ruby Khatun Khatun Published On 2017-06-17T09:36:43+05:30  |  Updated On 17 Jun 2017 9:36 AM IST
    Government of India bans Fixed dose combination of Glucosamine, Ibuprofen

    Department of Health and Family Welfare of Ministry of Health and Family Welfare, Government of India has banned fixed dose combinations of Glucosamine + Ibuprofen after finding that the said drug lacks rationality and therapeutic justification.


    Through a gazette notification, the Central government has banned the fixed dose combination of Glucosamine + Ibuprofen announcing that the drug fixed dose combination of Glucosamine + Ibuprofen is not rational.


    The decision was announced after the matter has been examined by the Subject Expert Committee constituted by the Central Government and the said Committee recommended to the Central Government that the said drug lacks rationality and therapeutic justification;


    After examination of the recommendations of the aforesaid Committee, the Central Government stated that it is satisfied that it is necessary and expedient in public interest to regulate by way of prohibition, the manufacture for sale, sale and distribution for human use of the said drug in the country; and hence prohibited the manufacture for sale, sale and distribution for human use of the drug fixed dose combination of Glucosamine + Ibuprofen with immediate effect.


    BannedCentral GovernmentDepartment of Health and Family WelfareDrugs and Cosmetics Actfixed dose combinationsGlucosamineGovernment of IndiaibuprofenMinistry of Health and Family Welfare

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok